LY 2469298

Known as: LY-2469298, LY2469298 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2011
01220112011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Purpose:AME-133v is a humanizedmonoclonal antibody engineered to have increased affinity to CD20 and mediate antibody-dependent… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Purpose:AME-133v is a humanizedmonoclonal antibody engineered to have increased affinity to CD20 and mediate antibody-dependent… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2012
2012
PURPOSE AME-133v is a humanized monoclonal antibody engineered to have increased affinity to CD20 and mediate antibody-dependent… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2011
2011
Patients with follicular lymphoma (FL), where position 158 of FcγR-IIIa is heterozygous valine/phenylalanine or homozygous… (More)
Is this relevant?
Review
2011
Review
2011
Over the last few years, new generations of anti-CD20 monoclonal antibodies (mAbs) have been developed for potential benefits… (More)
  • table I
  • table II
Is this relevant?